Cargando…

Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide with rising rates in parallel to obesity, type 2 diabetes, and metabolic syndrome. NAFLD includes pathologies ranging from simple steatosis (NAFL) to non-alcoholic steatohepatitis and cirrhosis (NASH), which may eve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Fanhong, Zhang, Yue, Han, Xu, Zeng, Min, Gao, Yi, Weng, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870871/ https://www.ncbi.nlm.nih.gov/pubmed/33574818 http://dx.doi.org/10.3389/fimmu.2020.609900

Ejemplares similares

Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma
por: Zeng, Fanhong, et al.
Publicado: (2021)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model
por: Zhang, Yue, et al.
Publicado: (2021)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: Erratum
por: Zhang, Yue, et al.
Publicado: (2022)

The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022)

HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axis
por: Zhang, Zhi, et al.
Publicado: (2021)

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools
por: Meli, Rosaria, et al.
Publicado: (2014)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
por: Novo, Erica, et al.
Publicado: (2022)

New Mechanisms of Bromelain in Alleviating Non-Alcoholic Fatty Liver Disease-Induced Deregulation of Blood Coagulation
por: Hu, Po-An, et al.
Publicado: (2022)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
por: Duan, Yamei, et al.
Publicado: (2022)

Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease
por: Zhou, Liangliang, et al.
Publicado: (2022)

Beyond Host Defense: Deregulation of Drosophila Immunity and Age-Dependent Neurodegeneration
por: Arora, Srishti, et al.
Publicado: (2020)

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease
por: Li, Sha, et al.
Publicado: (2019)

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Yang, Kailin, et al.
Publicado: (2022)

Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs
por: Weng, Jun, et al.
Publicado: (2021)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019)

Lineage tracing: technology tool for exploring the development, regeneration, and disease of the digestive system
por: Zhang, Yue, et al.
Publicado: (2020)

Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
por: Stiglund, Natalie, et al.
Publicado: (2019)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
por: Martínez-Chantar, María Luz, et al.
Publicado: (2021)

Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer
por: Jun, Eunsung, et al.
Publicado: (2019)

HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
por: Ripamonti, Chiara, et al.
Publicado: (2022)

Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression
por: Donelan, William, et al.
Publicado: (2022)

The association between non-alcoholic fatty liver disease and atopic dermatitis: a population-based cohort study
por: Gau, Shuo-Yan, et al.
Publicado: (2023)

Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
por: Paquissi, Feliciano Chanana
Publicado: (2016)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis
por: Ren, Ao, et al.
Publicado: (2023)

Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway
por: Nakamori, Yuki, et al.
Publicado: (2021)

Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

The Absence of STING Ameliorates Non-Alcoholic Fatty Liver Disease and Reforms Gut Bacterial Community
por: Zhang, Qiang, et al.
Publicado: (2022)

Live Imaging of Innate and Adaptive Immune Responses in the Liver
por: Li, Lu, et al.
Publicado: (2020)

Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic Steatohepatitis
por: Zhang, Zhi, et al.
Publicado: (2021)

NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis
por: Quenum, Akouavi Julite I., et al.
Publicado: (2021)

Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
por: Hundertmark, Jana, et al.
Publicado: (2018)

Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
por: Aghara, Hiral, et al.
Publicado: (2023)

Chronically Elevated O-GlcNAcylation Limits Nitric Oxide Production and Deregulates Specific Pro-Inflammatory Cytokines
por: Abramowitz, Lara K., et al.
Publicado: (2022)

Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
por: Fan, Yadong, et al.
Publicado: (2022)

Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
por: Oates, Jarren R., et al.
Publicado: (2023)

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
por: Du, Jingli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o4vhiraddtjr4a9q2s74d39o30